Evidence map›Paper›PMID 16601240›Full record

ArticleAmerican journal of respiratory cell and molecular biology2006

Dissection of the hyperadhesive phenotype of airway eosinophils in asthma.

Steven R Barthel, Nizar N Jarjour, Deane F Mosher, Mats W Johansson

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 58 citations in OpenAlex.

  1. α(M)β(2) integrin-mediated adhesion and motility of IL-5-stimulated eosinophils on periostin.American journal of respiratory cell and molecular biology · 2013
    Trial
  2. Proton pump inhibitors modulate esophageal epithelial barrier function and crosstalk with eosinophils.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2026
    Article
  3. Article
  4. Review
  5. Eosinophil-Epithelial Cell Interactions in Asthma.International archives of allergy and immunology · 2024
    Review
  6. Article
  7. Article
  8. αJournal of personalized medicine · 2021
    Article
  9. Review
  10. Fibrinogen Is a Specific Trigger for Cytolytic Eosinophil Degranulation.Journal of immunology (Baltimore, Md. : 1950) · 2020
    Article
  11. Review
  12. Article
  13. Article
  14. T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy.Laboratory investigation; a journal of technical methods and pathology · 2017
    Review
  15. IL-3 up-regulates and activates human eosinophil CD32 and αMβ2 integrin causing degranulation.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2017
    Article
  16. Review
  17. Article
  18. Article
  19. Eosinophilic bioactivities in severe asthma.The World Allergy Organization journal · 2016
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Steven R BarthelDepartment of Biomolecular Chemistry, University of Wisconsin-Madison, 4285A Medical Sciences Center, 1300 University Avenue, Madison, Wisconsin 53706-1532, USA.
Nizar N Jarjour
Deane F Mosher
Mats W Johansson
University of Wisconsin–Madison · USUniversity of Wisconsin System · US

Funding

ZOSUQUIDAR TRIHYDROCHLORIDE IN NEWLY DIAGNOSED AMLM01RR003186 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI MATLOUB, YOUSIF H · 1986 to 2007
$19.3M
SCOR--CELLULAR AND MOLECULAR MECHANISMS OF ASTHMAP50HL056396 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI BERTICS, PAUL JOHN · 1997 to 2006
$13.8M
RESEARCH TRAINING IN HEMATOLOGYT32HL007899 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI Jane Ellen Churpek · 1998 to 2026
$8.2M
NCRR NIH HHS M01 RR03186NHLBI NIH HHS HL56396NHLBI NIH HHS P50 HL056396NHLBI NIH HHS T32 HL007899
6 · The paper itself

Abstract

Asthma is characterized by appearance of eosinophils in the airway. Eosinophils purified from the airway 48 h after segmental antigen challenge are described as exhibiting greater adhesion to albumin-coated surfaces via an unidentified beta2 integrin and increased expression of alphaMbeta2 (CD11b/18) compared with purified blood eosinophils. We have investigated the determinants of this hyperadhesive phenotype. Airway eosinophils exhibited increased reactivity with the CBRM1/5 anti-alphaM activation-sensitive antibody as well as enhanced adhesion to VCAM-1 (CD106) and diverse ligands, including albumin, ICAM-1 (CD54), fibrinogen, and vitronectin. Purified blood eosinophils did not adhere to the latter diverse ligands. Enhanced adhesion of airway eosinophils was blocked by anti-alphaMbeta2. Podosomes, structures implicated in cell movement and proteolysis of matrix proteins, were larger and more common on airway eosinophils adherent to VCAM-1 when compared with blood eosinophils. Incubation of blood eosinophils with IL-5 replicated the phenotype of airway eosinophils. That is, IL-5 enhanced recognition of alphaM by CBRM1/5; stimulated alphaMbeta2-mediated adhesion to VCAM-1, albumin, ICAM-1, fibrinogen, and vitronectin; and increased podosome formation on VCAM-1. Thus, the hyperadhesion of airway eosinophils after antigen challenge is mediated by upregulated and activated alphaMbeta2.

Indexed as

Cell AdhesionAntibodiesAsthmaCD18 AntigensEosinophilsFibrinogenHumansIntercellular Adhesion Molecule-1Interleukin-5LigandsMacrophage-1 AntigenPhenotypeRespiratory SystemVascular Cell Adhesion Molecule-1VitronectinAntibodiesCD18 AntigensFibrinogenIntercellular Adhesion Molecule-1Interleukin-5LigandsMacrophage-1 AntigenVascular Cell Adhesion Molecule-1Vitronectin

Identifiers

PMID16601240
PMCPMC1550734
OpenAlexW2047230504

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.